LifeMD (LFMD)
(Delayed Data from NSDQ)
$9.94 USD
-0.47 (-4.51%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $9.93 -0.01 (-0.10%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LFMD 9.94 -0.47(-4.51%)
Will LFMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LFMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LFMD
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
Health Meets Lifestyle: How Hims & Hers Is Reshaping Everyday Wellness
LFMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside?
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth
Other News for LFMD
LifeMD (LFMD) Announces Key Leadership Changes
LifeMD appoints chief operating officer
LifeMD Names COO and Promotes Two Executives | LFMD Stock News
LifeMD names Webb Dray as Chief Operating Officer, promotes two execs
LifeMD to Report Second Quarter 2025 Financial Results on August 5 | LFMD Stock News